Skip to main content
Top
Published in: International Urology and Nephrology 8/2021

Open Access 01-08-2021 | Urology - Original Paper

Effect of a mobile digital intervention to enhance physical activity in individuals with metabolic disorders on voiding patterns measured by 24-h voided volume monitoring system: Kumejima Digital Health Project (KDHP)

Authors: Minoru Miyazato, Asuka Ashikari, Koshi Nakamura, Takehiro Nakamura, Kiyoto Yamashiro, Tsugumi Uema, Moriyuki Uehara, Hiroaki Masuzaki, Seiichi Saito, Shiro Maeda, Hajime Ishida, Masayuki Matsushita

Published in: International Urology and Nephrology | Issue 8/2021

Login to get access

Abstract

Purpose

To evaluate the effect of a mobile digital intervention on voiding patterns, we performed 24-h voided volume monitoring in individuals with metabolic disorders.

Methods

Participants with metabolic disorders were grouped into either the intervention group (n = 17), who had access to a smartphone app (CARADA), or the non-intervention group (n = 11), who did not. Urine monitoring was conducted for 24 h using a novel digital self-health monitoring system for urine excretion (s-HMSU). Body weight, abdominal circumference, blood pressure, and biomarkers were measured.

Results

Physical findings and blood test results at baseline and 6 months indicated no significant between-group differences. Night-time frequency did not change between baseline and 6 months in the intervention group but significantly worsened at 6 months in the non-intervention group, as compared to baseline (1.0 ± 0.7 vs. 1.5 ± 0.5, p < 0.05). The change in night-time frequency over 6 months did not differ between the intervention and non-intervention groups. Furthermore, the change in hours of undisturbed sleep over 6 months did not differ between the two groups. However, compared with baseline, nocturnal polyuria index tended to worsen at 6 months in the non-intervention group.

Conclusion

Our study results suggest that mobile digital intervention might be useful for behavioral therapy to improve night-time frequency and urine production and that s-HMSU might be beneficial for confirming the prevention of progress in individuals with metabolic disorders, which can aid in modifying lifestyle.
Literature
5.
go back to reference Weiss JP, Blaivas JG (2002) Nocturnal polyuria versus overactive bladder in nocturia. Urology 60(Suppl 1):28–32 (discussion 32)CrossRef Weiss JP, Blaivas JG (2002) Nocturnal polyuria versus overactive bladder in nocturia. Urology 60(Suppl 1):28–32 (discussion 32)CrossRef
11.
go back to reference [Definition and the diagnostic standard for metabolic syndrome--Committee to Evaluate Diagnostic Standards for Metabolic Syndrome] (2005) Nihon Naika Gakkai zasshi J Jpn Soc Intern Med 94(4):794–809 [Definition and the diagnostic standard for metabolic syndrome--Committee to Evaluate Diagnostic Standards for Metabolic Syndrome] (2005) Nihon Naika Gakkai zasshi J Jpn Soc Intern Med 94(4):794–809
13.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419. https://doi.org/10.1007/BF00280883CrossRef Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419. https://​doi.​org/​10.​1007/​BF00280883CrossRef
19.
20.
go back to reference Kusunoki-Tsuji C, Araki SI, Kume S, Chin-Kanasaki M, Osawa N, Morino K, Sekine O, Ugi S, Kashiwagi A, Maegawa H (2018) Impact of obesity on annual medical expenditures and diabetes care in Japanese patients with type 2 diabetes mellitus. J Diabetes Investig 9(4):776–781. https://doi.org/10.1111/jdi.12766CrossRefPubMed Kusunoki-Tsuji C, Araki SI, Kume S, Chin-Kanasaki M, Osawa N, Morino K, Sekine O, Ugi S, Kashiwagi A, Maegawa H (2018) Impact of obesity on annual medical expenditures and diabetes care in Japanese patients with type 2 diabetes mellitus. J Diabetes Investig 9(4):776–781. https://​doi.​org/​10.​1111/​jdi.​12766CrossRefPubMed
23.
go back to reference Aoki Y, Matsuta Y, Okada M, Matsumoto C, Kusaka Y, Yokoyama O (2013) Nocturia is associated with the incidence of metabolic syndrome: a four-year longitudinal study in Japanese men and women. Neurourol Urodyn 32(6):901–902 Aoki Y, Matsuta Y, Okada M, Matsumoto C, Kusaka Y, Yokoyama O (2013) Nocturia is associated with the incidence of metabolic syndrome: a four-year longitudinal study in Japanese men and women. Neurourol Urodyn 32(6):901–902
Metadata
Title
Effect of a mobile digital intervention to enhance physical activity in individuals with metabolic disorders on voiding patterns measured by 24-h voided volume monitoring system: Kumejima Digital Health Project (KDHP)
Authors
Minoru Miyazato
Asuka Ashikari
Koshi Nakamura
Takehiro Nakamura
Kiyoto Yamashiro
Tsugumi Uema
Moriyuki Uehara
Hiroaki Masuzaki
Seiichi Saito
Shiro Maeda
Hajime Ishida
Masayuki Matsushita
Publication date
01-08-2021
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 8/2021
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-021-02867-x

Other articles of this Issue 8/2021

International Urology and Nephrology 8/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.